Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Buchanan MR and Hirsh J | Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits. | 1984 Jul-Aug | Arteriosclerosis | pmid:6380468 |
| McIntosh GH et al. | Influence of dietary fats on blood coagulation and prostaglandin production in the common marmoset. | 1987 Mar-Apr | Arteriosclerosis | pmid:3107535 |
| Best LC et al. | Studies on the role of calcium in the control of thromboxane B2 production. | 1980 | Artery | pmid:6783015 |
| Silver MJ et al. | A model system for studying initial events in atherosclerosis. | 1980 | Artery | pmid:7000044 |
| Kawai VK et al. | Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome. | 2014 | Arthritis Care Res (Hoboken) | pmid:24022862 |
| Kojima F et al. | Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. | 2004 | Arthritis Res. Ther. | pmid:15225371 |
| Chin JE and Lin YA | Effects of recombinant human interleukin-1 beta on rabbit articular chondrocytes. Stimulation of prostanoid release and inhibition of cell growth. | 1988 | Arthritis Rheum. | pmid:3263134 |
| Simon LS et al. | Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. | 1998 | Arthritis Rheum. | pmid:9751091 |
| Shi T et al. | Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. | 2006 | Arthritis Rheum. | pmid:16868978 |
| Anzellotti P et al. | Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences. | 2011 | Arthritis Rheum. | pmid:21360514 |
| Stein CM et al. | Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. | 1996 | Arthritis Rheum. | pmid:8670323 |
| Cracowski JL et al. | Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. | 2001 | Arthritis Rheum. | pmid:11352247 |
| Ferro D et al. | Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. | 1999 | Arthritis Rheum. | pmid:10616019 |
| Fauler J et al. | Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis. | 1994 | Arthritis Rheum. | pmid:8129769 |
| Walker JS et al. | Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders". | 1997 | Arthritis Rheum. | pmid:9365082 |
| Weinblatt M et al. | The effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis. | 1991 | Arthritis Rheum. | pmid:2012627 |
| Vega-Ostertag M et al. | Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. | 2004 | Arthritis Rheum. | pmid:15457460 |
| Wakamoto S et al. | Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro. | 2005 | Artif Cells Blood Substit Immobil Biotechnol | pmid:15960075 |
| Szebeni J et al. | Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1. | 1997 | Artif Cells Blood Substit Immobil Biotechnol | pmid:9242930 |
| Gu YJ et al. | Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate. | 1993 | Artif Organs | pmid:8338443 |
| Simoni J et al. | Biocompatibility of hemoglobin solutions. II. The inflammatory reaction of human monocytes and mouse peritoneal macrophages. | 1990 | Artif Organs | pmid:2350262 |
| Mahiout A et al. | Dialyzer membranes: effect of surface area and chemical modification of cellulose on complement and platelet activation. | 1987 | Artif Organs | pmid:3036050 |
| Hatori N et al. | Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass. | 1994 | Artif Organs | pmid:7887827 |
| Kim WG et al. | Is avoidance of air contact necessary for the in vitro evaluation of thrombogenicity in mechanical circulatory assist devices? | 2000 | Artif Organs | pmid:11012543 |
| Jörres A et al. | Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. | 1994 | Artif Organs | pmid:7527629 |
| Mahiout A et al. | Eicosanoid release as laboratory indicator of biocompatibility. | 1989 | Artif Organs | pmid:2504134 |
| Feola M et al. | Biocompatibility of hemoglobin solutions. I. Reactions of vascular endothelial cells to pure and impure hemoglobins. | 1989 | Artif Organs | pmid:2669694 |
| Yoshino T et al. | Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor. | 2005 | Arzneimittelforschung | pmid:16080279 |
| Okuda Y et al. | Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy. | 1992 | Arzneimittelforschung | pmid:1642679 |
| Küsters S et al. | Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells. | 2002 | Arzneimittelforschung | pmid:11878205 |
| Moriau M et al. | Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects. | 1993 | Arzneimittelforschung | pmid:8457235 |
| Legnani C et al. | Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects. | 1993 | Arzneimittelforschung | pmid:8457236 |
| Hladovec J | Prostaglandins and endothelial stability. | 1981 | Arzneimittelforschung | pmid:7011332 |
| Ortega MP et al. | Effect of etersalate on human platelet responsiveness. A study in healthy volunteers. | 1987 | Arzneimittelforschung | pmid:2883981 |
| Horiguchi T et al. | Study on the usefulness of seratrodast in the treatment of chronic pulmonary emphysema. | 2002 | Arzneimittelforschung | pmid:12442639 |
| Tanaka M et al. | Disposition and effect of the new thromboxane synthetase inhibitor 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid in man. | 1990 | Arzneimittelforschung | pmid:2397009 |
| Kangasaho M | Effects of lidocaine, codeine and vadocaine hydrochloride on platelet aggregation in human platelet-rich plasma. | 1988 | Arzneimittelforschung | pmid:2840087 |
| Maurin N | Routine measurement of thromboxane B2 and the prostacyclin metabolite 6-keto-prostaglandin F1 alpha in plasma. | 1986 | Arzneimittelforschung | pmid:3778554 |
| Perzborn E et al. | Action of the novel selective thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid on vascular smooth muscle preparations. | 1989 | Arzneimittelforschung | pmid:2624598 |
| Supanz S et al. | Effects of the novel thromboxane (TXA2) receptor antagonist linotroban on inulin and para-aminohippuric acid clearances in the conscious male and female rat. | 1997 | Arzneimittelforschung | pmid:9342416 |
| Berti F et al. | Protective effect of furosemide combined with non-steroidal anti-inflammatory drugs administered by inhalation route on guinea-pigs anaphylaxis model. | 1995 | Arzneimittelforschung | pmid:8595068 |
| Ohmuro S et al. | Protective effect of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on myocardial damage due to coronary occlusion and reperfusion in rabbit. | 1992 | Arzneimittelforschung | pmid:1586378 |
| Uehara S et al. | Effects of the calcium antagonist nifedipine on thromboxane B2 level and platelet aggregation in hypertensive patients. | 1986 | Arzneimittelforschung | pmid:3814228 |
| Matsuzawa S et al. | Ibudilast, a phosphodiesterase inhibitor, in combination with low-dose aspirin potently inhibits guinea pig carotid artery thrombosis without extending bleeding time and causing gastric mucosal injury. | 2012 | Arzneimittelforschung | pmid:22945770 |
| Tubaro E et al. | Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug. | 2001 | Arzneimittelforschung | pmid:11642006 |
| Depin JC et al. | Pharmacodynamics and antithrombotic effects after intravenous administration of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. | 1994 | Arzneimittelforschung | pmid:7848332 |
| Asai F et al. | In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate. | 1991 | Arzneimittelforschung | pmid:1898421 |
| Rettkowski W et al. | Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation. | 1982 | Arzneimittelforschung | pmid:6805480 |
| Kawakage M et al. | Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs. | 1991 | Arzneimittelforschung | pmid:1815524 |
| Keller F et al. | Thromboxane B2 blood levels and incipient system clotting in heparin free hemodialysis. | 1995 Apr-Jun | ASAIO J. | pmid:7640422 |
| Amrani DL et al. | Hemostatic evaluation of Sarns/3M-VAD implantation in calves. | 1991 Jul-Sep | ASAIO Trans | pmid:1751163 |
| Mahiout A et al. | Prostaglandin production and extracorporeal complement activation by dialyzer membranes. | 1986 Jul-Sep | ASAIO Trans | pmid:3490868 |
| Ito RK et al. | Monitoring platelet interactions with prosthetic graft implants in a canine model. | 1990 Jul-Sep | ASAIO Trans | pmid:2147555 |
| Takayama K et al. | Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. | 1991 Jul-Sep | ASAIO Trans | pmid:1836334 |
| Hain H et al. | Prostaglandin E2, thromboxane B2, and leukotriene B4 release from peritoneal macrophages by different osmotic agents in nonuremic guinea pigs. | 1988 Jul-Sep | ASAIO Trans | pmid:2848562 |
| Mahiout A et al. | Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies. | 1988 Jul-Sep | ASAIO Trans | pmid:3058187 |
| Murphy KJ et al. | Low dose supplementation with two different marine oils does not reduce pro-inflammatory eicosanoids and cytokines in vivo. | 2006 | Asia Pac J Clin Nutr | pmid:16837436 |
| Eynard AR et al. | Platelet formation of 12-hydroxyeicosatetraenoic acid and thromboxane B2 is increased in type IIA hypercholesterolemic subjects. | 1986 | Atherosclerosis | pmid:3085686 |
| Bailey JM et al. | Anti-inflammatory drugs in experimental atherosclerosis. Part 4. Inhibition of atherosclerosis in vivo and thromboxane synthesis and platelet aggregation in vitro. | 1979 | Atherosclerosis | pmid:454516 |
| Tremoli E et al. | Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits. | 1982 | Atherosclerosis | pmid:7073794 |
| Lovati MR et al. | Reduced platelet aggregability and increased vascular prostacyclin formation in a variant rat strain (IVA-SIV) with endogenous hypertriglyceridemia. | 1988 | Atherosclerosis | pmid:3214476 |
| Menys VC et al. | Spontaneous platelet aggregation in whole blood is increased in non-insulin-dependent diabetes mellitus and in female but not male patients with primary dyslipidemia. | 1995 | Atherosclerosis | pmid:7772062 |
| Fredenrich A et al. | Effects of low density and high density lipoproteins isolated from non-insulin dependent diabetic patients on prostaglandin secretion by mouse macrophage cell line P388D1. | 1999 | Atherosclerosis | pmid:9920525 |
| Chiang MT et al. | Lipoprotein, lecithin:cholesterol acyl transferase and acetyl CoA carboxylase in stroke-prone spontaneously hypertensive rats fed a diet high in eicosapentaenoic acid. | 1994 | Atherosclerosis | pmid:7912508 |
| Croft KD et al. | Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia. | 1990 | Atherosclerosis | pmid:2173612 |
| Livio M et al. | Differential effects of itanoxone--a new hypolipidemic and hypouricemic drug--on platelet and vascular prostaglandin generation in rats. | 1981 | Atherosclerosis | pmid:7259827 |
| Malle E et al. | Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp(a) concentrations. | 1991 | Atherosclerosis | pmid:1832537 |
| Jeng JH et al. | Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. | 2007 | Atherosclerosis | pmid:16797553 |
| Bräutigam R et al. | Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia. | 1997 | Atherosclerosis | pmid:9180250 |
| Beatty CH et al. | Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis. | 1985 | Atherosclerosis | pmid:3924062 |
| Dembińska-Kièć A et al. | Prostacyclin-dependent differences in TXA2 formation by platelets from normal and atherosclerotic rabbits. | 1979 | Atherosclerosis | pmid:224890 |
| Davì G et al. | Effects of synvinolin on platelet aggregation and thromboxane B2 synthesis in type IIa hypercholesterolemic patients. | 1989 | Atherosclerosis | pmid:2803348 |
| McClelland S et al. | Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse. | 2009 | Atherosclerosis | pmid:18514659 |
| Puccetti L et al. | Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. | 2011 | Atherosclerosis | pmid:21056418 |
| Balteskard L et al. | Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared with men. | 1993 | Atherosclerosis | pmid:8257457 |
| Huang K et al. | Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. | 2002 | Atherosclerosis | pmid:11947907 |
| Kleinedler JJ et al. | A dietary approach to increase in-stent stenosis and face validity of a rat model for arterial angioplasty and stenting. | 2011 | Atherosclerosis | pmid:21982412 |
| Beitz J et al. | Endogenous lipoproteins modify the thromboxane formation capacity of platelets. | 1986 | Atherosclerosis | pmid:3718615 |
| Véricel E et al. | The influence of low intake of n-3 fatty acids on platelets in elderly people. | 1999 | Atherosclerosis | pmid:10525140 |
| Ledwidge MT et al. | In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin? | 2012 | Atherosclerosis | pmid:22326030 |
| Mustad V et al. | Seasonal variation in parameters related to coronary heart disease risk in young men. | 1996 | Atherosclerosis | pmid:8879440 |
| Tremoli E et al. | Dietary interventions in north Karelia, Finland and south Italy. Modification of thromboxane B2 formation in platelets of male subjects only. | 1986 | Atherosclerosis | pmid:3964338 |
| Abeywardena MY et al. | Long-term saturated fat supplementation in the rat causes an increase in PGI2/TXB2 ratio of platelet and vessel wall compared to n-3 and n-6 dietary fatty acids. | 1987 | Atherosclerosis | pmid:2820432 |
| Cyrus T et al. | Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin. | 2006 | Atherosclerosis | pmid:16326168 |
| Bogani P et al. | Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. | 2007 | Atherosclerosis | pmid:16488419 |
| Singer P et al. | Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. | 1986 | Atherosclerosis | pmid:3026412 |
| Falco A et al. | Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. | 2005 | Atherosclerosis | pmid:16285996 |
| Gross PL et al. | Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses. | 1991 | Atherosclerosis | pmid:1878012 |
| Singer P et al. | Blood pressure- and lipid-lowering effect of mackerel and herring diet in patients with mild essential hypertension. | 1985 | Atherosclerosis | pmid:3000395 |
| Clark IA and Hunt NH | Increased production of arachidonate metabolites by peritoneal cells of mice infected with Plasmodium vinckei vinckei. | 1986 | Aust J Exp Biol Med Sci | pmid:3579736 |
| Croft KD et al. | Dietary modification of platelet and renal prostaglandins. | 1984 | Aust N Z J Med | pmid:6393931 |
| Herd CM et al. | A dose-ranging study of the antiplatelet effect of enteric coated aspirin in man. | 1987 | Aust N Z J Med | pmid:3476058 |
| Vial JH et al. | Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin. | 1990 | Aust N Z J Med | pmid:2126726 |
| Cooper TM and Ingram DM | Platelet function in the peri-operative period. | 1991 | Aust N Z J Surg | pmid:1829351 |
| Tachi M et al. | Mass spectrometric determination of prostanoids in rat hypothalamic paraventricular nucleus microdialysates. | 2014 | Auton Neurosci | pmid:24447364 |
| Shen D and Wang Y | Effects of hypoxia on platelet activation in pilots. | 1994 | Aviat Space Environ Med | pmid:7945133 |
| Ylikorkala O and Viinikka L | The role of prostaglandins in obstetrical disorders. | 1992 | Baillieres Clin Obstet Gynaecol | pmid:1477999 |
| Markuszewski L et al. | Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? | 2006 | Basic Clin. Pharmacol. Toxicol. | pmid:16635110 |
| Jin YR et al. | An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. | 2005 | Basic Clin. Pharmacol. Toxicol. | pmid:16128910 |
| Kerola M et al. | Effects of nimesulide, acetylsalicylic acid, ibuprofen and nabumetone on cyclooxygenase-1- and cyclooxygenase-2-mediated prostanoid production in healthy volunteers ex vivo. | 2009 | Basic Clin. Pharmacol. Toxicol. | pmid:19152549 |